Triamcinolone Ophthalmic Dosage
Medically reviewed by Drugs.com. Last updated on Dec 9, 2024.
Applies to the following strengths: 40 mg/mL
Usual Adult Dose for:
Usual Pediatric Dose for:
Additional dosage information:
Usual Adult Dose for Uveitis
4 mg (100 microliters of 40 mg/mL suspension) with subsequent dosage as needed over the course of treatment
Comments:
- Strict aseptic technique is mandatory.
- The vial should be vigorously shaken for 10 seconds before use.
- Prior to withdrawal, the suspension should be inspected for clumping or granular appearance (agglomeration).
- After withdrawal, the suspension should be injected without delay.
- Careful technique should be employed to avoid the possibility of entering a blood vessel or introducing organisms that can cause infection.
Uses:
- Treatment of sympathetic ophthalmia
- Treatment of temporal arteritis
- Treatment of uveitis
- Treatment of ocular inflammatory conditions unresponsive to topical
Usual Adult Dose for Temporal Arteritis
4 mg (100 microliters of 40 mg/mL suspension) with subsequent dosage as needed over the course of treatment
Comments:
- Strict aseptic technique is mandatory.
- The vial should be vigorously shaken for 10 seconds before use.
- Prior to withdrawal, the suspension should be inspected for clumping or granular appearance (agglomeration).
- After withdrawal, the suspension should be injected without delay.
- Careful technique should be employed to avoid the possibility of entering a blood vessel or introducing organisms that can cause infection.
Uses:
- Treatment of sympathetic ophthalmia
- Treatment of temporal arteritis
- Treatment of uveitis
- Treatment of ocular inflammatory conditions unresponsive to topical
Usual Adult Dose for Vitrectomy
1 to 4 mg (25 to 100 microliters of 40 mg/mL suspension) administered intravitreally
Comments:
- Strict aseptic technique is mandatory.
- The vial should be vigorously shaken for 10 seconds before use.
- Prior to withdrawal, the suspension should be inspected for clumping or granular appearance (agglomeration).
- After withdrawal, the suspension should be injected without delay.
- Careful technique should be employed to avoid the possibility of entering a blood vessel or introducing organisms that can cause infection.
Use: Visualization during vitrectomy
Usual Pediatric Dose for Uveitis
4 mg (100 microliters of 40 mg/mL suspension) with subsequent dosage as needed over the course of treatment
Comments:
- Strict aseptic technique is mandatory.
- The vial should be vigorously shaken for 10 seconds before use.
- Prior to withdrawal, the suspension should be inspected for clumping or granular appearance (agglomeration).
- After withdrawal, the suspension should be injected without delay.
- Careful technique should be employed to avoid the possibility of entering a blood vessel or introducing organisms that can cause infection.
Uses:
- Treatment of sympathetic ophthalmia
- Treatment of temporal arteritis
- Treatment of uveitis
- Treatment of ocular inflammatory conditions unresponsive to topical
Usual Pediatric Dose for Temporal Arteritis
4 mg (100 microliters of 40 mg/mL suspension) with subsequent dosage as needed over the course of treatment
Comments:
- Strict aseptic technique is mandatory.
- The vial should be vigorously shaken for 10 seconds before use.
- Prior to withdrawal, the suspension should be inspected for clumping or granular appearance (agglomeration).
- After withdrawal, the suspension should be injected without delay.
- Careful technique should be employed to avoid the possibility of entering a blood vessel or introducing organisms that can cause infection.
Uses:
- Treatment of sympathetic ophthalmia
- Treatment of temporal arteritis
- Treatment of uveitis
- Treatment of ocular inflammatory conditions unresponsive to topical
Usual Pediatric Dose for Vitrectomy
1 to 4 mg (25 to 100 microliters of 40 mg/mL suspension) administered intravitreally
Comments:
- Strict aseptic technique is mandatory.
- The vial should be vigorously shaken for 10 seconds before use.
- Prior to withdrawal, the suspension should be inspected for clumping or granular appearance (agglomeration).
- After withdrawal, the suspension should be injected without delay.
- Careful technique should be employed to avoid the possibility of entering a blood vessel or introducing organisms that can cause infection.
Use: Visualization during vitrectomy
Renal Dose Adjustments
Renal insufficiency: Use with caution
Liver Dose Adjustments
Data not available
Precautions
Consult WARNINGS section for additional precautions.
Dialysis
Data not available
Other Comments
Administration advice:
- The manufacturer product information should be consulted.
Storage requirements:
- Do not freeze.
- Protect from light.
More about triamcinolone ophthalmic
- Check interactions
- Compare alternatives
- Reviews (1)
- Side effects
- During pregnancy
- Drug class: ophthalmic steroids
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
See also:
Vabysmo
Vabysmo eye injection is used to treat eye diseases neovascular (wet) age-related macular ...
Eylea
Eylea is used to treat neovascular (wet) age-related macular degeneration (AMD), macular edema ...
Botox
Botox is used cosmetically to reduce facial lines and wrinkles and for medical purposes for ...
Eylea HD
Eylea HD is used to treat neovascular (wet) age-related macular degeneration (AMD), diabetic ...
Lucentis
Lucentis is used to treat the wet form of age-related macular degeneration. Learn about side ...
Ozurdex
Ozurdex is an implant injected into the eye to treat swelling that may occur when there is a ...
Pavblu
Pavblu (aflibercept-ayyh) is a biosimilar to Eylea that may be used to treat the following eye ...
Maxidex
Maxidex is used for conjunctivitis, conjunctivitis, allergic, cyclitis, iritis, keratitis, macular ...
Yesafili
Yesafili (aflibercept-jbvf) is an interchangeable biosimilar to Eylea that may be given by ...
Ranibizumab ophthalmic
Ranibizumab ophthalmic is used for diabetic macular edema, diabetic retinopathy, macular ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.